Search Results - Wortel, R.C

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    EP-1303: Orchiectomy and radiotherapy for stage I-II testicular seminoma: Side effects, body image and sexual functioning

    EP-1303: Orchiectomy and radiotherapy for stage I-II testicular seminoma: Side effects, body image and sexual functioning by Wortel, R.C, Incrocci, L

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer

    Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostat... by Teunissen, F.R., Wortel, R.C., Wessels, F.J., Claes, A., van de Pol, S.M.G., Rasing, M.J.A., Meijer, R.P., van Melick, H.H.E., de Boer, J.C.J., Verkooijen, H.M., van der Voort van Zyp, J.R.N.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    OC-0256: Dose-surface maps to explore acute gastrointestinal toxicity following prostate radiotherapy

    OC-0256: Dose-surface maps to explore acute gastrointestinal toxicity following prostate radiotherapy by Witte, M.G, Wortel, R.C, Incrocci, L, Pos, F.J, Lebesque, J.V, Van der Heide, U.A, Van Herk, M, Heemsbergen, W.D

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    OC-0060: Health-related quality of life from the prostate hypofractionation (HYPRO) trial

    OC-0060: Health-related quality of life from the prostate hypofractionation (HYPRO) trial by Pos, F., Wortel, R.C., Heemsbergen, W.D., Oomen-de Hoop, E., Incrocci, L.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    PV-0554: Patient-reported outcomes from the phase III prostate HYPRO trial: urinary toxicity

    PV-0554: Patient-reported outcomes from the phase III prostate HYPRO trial: urinary toxicity by Wortel, R.C., Incrocci, L., Pos, F.J., Smeenk, R.J., Krol, A.D.G., Aluwini, S., Witte, M.G., Heijmen, B.J.M., Heemsbergen, W.D.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    First-in-man: neurovascular-sparing magnetic resonance-guided adaptive radiotherapy for localized prostate cancer for preservation of erectile function

    First-in-man: neurovascular-sparing magnetic resonance-guided adaptive radiotherapy for localized prostate cancer for preservation of erectile function by Teunissen, F.R., Wortel, R.C., Van Der Velden, J.M., Hes, J., Van Melick, H.H.E., Meijer, R.P., Verkooijen, H.M., De Groot-Van Breugel, E.N., De Boer, J.C.J., Van Der Voort Van Zyp, J.R.N.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    715 - Hyprofractionated vs conventionally fractionated radiotherapy for prostate cancer: 7-year outcome from the Dutch HYPRO trial

    715 - Hyprofractionated vs conventionally fractionated radiotherapy for prostate cancer: 7-year outcome from the Dutch HYPRO trial by Wortel, R.C., De Vries, K., Pos, F.J., Oomen-De Hoop, E., Heemsbergen, W.D., Incrocci, L.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Hyprofractionated vs conventionally fractionated radiotherapy for prostate cancer: 7-year outcome from the Dutch HYPRO trial

    Hyprofractionated vs conventionally fractionated radiotherapy for prostate cancer: 7-year outcome from the Dutch HYPRO trial by Wortel, R.C., De Vries, K., Pos, F.J., Oomen-De Hoop, E., Heemsbergen, W.D., Incrocci, L.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: